Company Overview and News

0
Carlos Ghosn Rules Out Acquisition of Nissan by Renault - WSJ

2018-06-22 wsj
TOKYO—Carlos Ghosn said Friday there was “zero chance” Renault SA would acquire partners Nissan Motor Co. and Mitsubishi Motors Corp., bringing more clarity to the direction of a 19-year-old alliance that is preparing for a future without its chief architect.
MMTOY RNO 7211 MMTOF

5
'Zero' chance of Renault taking over Nissan, Mitsubishi: Ghosn - Channel NewsAsia

2018-06-22 channelnewsasia
Renault SA absorbing Nissan Motor Co. and Mitsubishi Motors Corp is not an option as the carmakers look to strengthen their partnership while retaining their autonomy, alliance chairman Carlos Ghosn said on Friday.
VLKAF MMTOY TM 7203 TYT RNO TOYOF 7211 MMTOF

5
'Zero' chance of Renault taking over Nissan, Mitsubishi: Ghosn

2018-06-22 reuters
TOKYO (Reuters) - Renault SA (RENA.PA) absorbing Nissan Motor Co. (7201.T) and Mitsubishi Motors Corp (7211.T) is not an option as the carmakers look to strengthen their partnership while retaining their autonomy, alliance chairman Carlos Ghosn said on Friday.
VLKAF MMTOY TM 7203 TYT RNO TOYOF 7211 MMTOF

0
‘Zero chance’ Renault will make Nissan and Mitsubishi full subsidiaries, alliance CEO Carlos Ghosn says

2018-06-22 japantimes.co.jp
Carlos Ghosn, chairman and chief executive officer of the alliance between Renault SA, Mitsubishi Motors Corp. and Nissan Motor Co., said Friday there is “zero chance” that the French automaker will make the two other companies wholly owned subsidiaries.
MMTOY RNO 7211 MMTOF

7
Magnitude 6.1 quake in Japan's Osaka area kills three, stops factories

2018-06-18 theedgemarkets
TOKYO (June 18): A magnitude 6.1 earthquake shook Osaka, Japan's second-biggest metropolis, early on Monday, killing three people, halting factory lines in an industrial area and bursting water mains, government and company officials said.
DKILY TM TYT TOYOF HHPG DKILF HHPD MMTOY 7203 KUBTY 6367 7211 MMTOF

7
Osaka earthquake causes auto and electronics plants to suspend operations

2018-06-18 japantimes.co.jp
OSAKA – A powerful earthquake that hit Osaka and surrounding areas on Monday affected a number of large businesses, forcing Honda Motor Co., Panasonic Corp. and other well-known manufacturers to suspend production and retailers to close.
DKILF PCRFY DKILY MMTOY TM 7203 TYT 6367 TOYOF 7211 MMTOF

5
Deaths feared, plants and trains halted after Osaka quake

2018-06-18 theedgemarkets
TOKYO (June 18): Several people were feared dead after a strong earthquake hit Osaka on Monday morning, rattling one of Japan’s industrial heartlands and halting trains and factories across the region.
PCRFY MMTOY TM 7203 TYT TOYOF 7211 MMTOF

2
Carlos Ghosn’s biggest test yet: how to untie the Renault-Nissan-Mitsubishi knot in the tech age

2018-06-16 scmp
The automotive world’s turnaround wunderkind and globalist par excellence says the industry’s future lies in services that combine technology and engines with applications
MMTOY GM.WS.A GM.WS.B GM.WS.C GM GM.WSB 7211 MMTOF

1
Ghosn Faces Investor Showdown on $9 Million Renault Pay - Bloomberg

2018-06-15 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
VLKAF MMTOY 7211 MMTOF

3
Japan firms to introduce electric vehicles in PH

2018-06-14 business.inquirer.net
Global auto giants Nissan and Mitsubishi are making a push to introduce their electric vehicles in the Philippines as efforts to promote the local market fall into place, according to an industry group.
MER MMTOY 7211 MMTOF

0
Malaysia PM floats new national car project

2018-06-11 channelnewsasia
TOKYO: Malaysia's newly-elected Prime Minister Mahathir Mohamad on Monday (Jun 11) floated the possibility of a national car project, despite the problems of a similar endeavour started during his previous term decades ago.
MMTOY 7211 MMTOF

0
Malaysia looks to Japan

2018-06-11 theedgemarkets
KUALA LUMPUR: The government’s fight against corruption, led by Prime Minister Tun Dr Mahathir Mohamad, is expected to lead to an improved business environment with heightened transparency, and Japanese investors are already taking notice, said the Japan External Trade Organisation’s (Jetro) Malaysian office managing director Akira Kajita.
MMTOY KMGGF 7211 MMTOF

17
Box (BOX) CEO Aaron Levie on Q1 2019 Results - Earnings Call Transcript

2018-05-31 seekingalpha
Good afternoon. My name is Christine and I will be your conference operator today. At this time, I would like to welcome everyone to the Box First Quarter Fiscal 2019 Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question-and-answer session. [Operator Instructions] Thank you. Alice Lopatto, Head of Investor Relations, you may begin your conference.
STI.WS.B STI.WS.A MS.PRE MS.PRF MS.PRG MS.PRA MMTOY STI MS.PRI MS.PRK STI-A STI.PRE MS 7211 MMTOF

6
Nissan to cut North American production by up to 20% - Nikkei Asian Review

2018-05-29 asia.nikkei
As well as being able to load content faster than ever before, you'll now find it's much easier to find all the content you need about the Asian business world.
MMTOY GM.WS.A TM GM.WS.B GM.WS.C 7203 TYT GM GM.WSB TOYOF 7211 MMTOF

10
Toyota touts free trade in opposition to U.S. auto tariffs

2018-05-27 japantimes.co.jp
Toyota Motor Corp. said Thursday it is opposed to the U.S. move to raise tariffs on imported vehicles, which could hit the domestic auto industry and economy.
7261 MZDAY TM TYT TOYOF VLKAF MMTOY GM.WS.A GM.WS.B MZDAF GM.WS.C 7203 GM 500570 GM.WSB TATAMOTORS 7211 MMTOF TTM

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

2018-06-22 - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2018-06-22 - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...